Drug Profile
GO 6976
Alternative Names: GOE 6976Latest Information Update: 06 Mar 2008
Price :
$50
*
At a glance
- Originator Goedecke
- Developer Calbiochem; Goedecke
- Class Antivirals; Small molecules
- Mechanism of Action Protein kinase C inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer; HIV infections
Most Recent Events
- 06 Mar 2008 Discontinued - Preclinical for Cancer in USA (unspecified route)
- 06 Mar 2008 Discontinued - Preclinical for HIV infections treatment in Germany (unspecified route)
- 31 Jul 2000 Profile reviewed but no significant changes made